ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 581,25
-0,67%
Dow Jones
40 211,72
0,53%
DAX
18 500,78
-0,53%
Brent Oil
83,76
-0,69%
Bitcoin
63 130,30
-2,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
05/10/201715h18Business WireTeva Announces tomy’s Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelo...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/10/201715h26Business WireTeva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL & Launch of Generic Glatiramer Acetate...NYSE:TEVATeva Pharmaceutical Industries Ltd
25/09/201720h38Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
25/09/201720h29Business WireTeva Announces Reintroduction of Generic Depo-Provera® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/09/201704h50PR Newswire (US)TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Dead...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201709h02Dow Jones NewsMakers Of Opioids Are Asked For Data -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201700h35Dow Jones NewsStates Push Ahead With Investigation Into Opioid PainkillersNYSE:TEVATeva Pharmaceutical Industries Ltd
20/09/201700h15Dow Jones NewsADRs End MixedNYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201716h00Business WireTeva & Nuvelution Pharma Partner to Accelerate Development of AUSTEDO® (deutetrabenazine) Tablets for Use in Tourette Syndro...NYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201713h30Business WireTeva Completes Amendment to Credit FacilitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
19/09/201709h02Dow Jones NewsTeva Sells Women's Health Assets -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201717h30Business WireNew Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic ConditionsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201716h58Dow Jones NewsTeva Sells Slate of Women's Health Products in Debt-Reducing MovesNYSE:TEVATeva Pharmaceutical Industries Ltd
18/09/201714h07Business WireTeva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201715h00PR Newswire (US)FinancialInsiders.com Earnings Recap Week Ending September 15th, 2017NYSE:TEVATeva Pharmaceutical Industries Ltd
15/09/201709h46Dow Jones NewsIndivior Files New Lawsuits for Alleged Patent InfringementNYSE:TEVATeva Pharmaceutical Industries Ltd
14/09/201714h00Business WireTeva to Present Data for AUSTEDO® (deutetrabenazine) Tablets and Other Research at the 2017 Psych CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201723h15Dow Jones NewsADRs End Mostly Higher; JD Trades ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201714h00Business WireTeva Receives FDA Priority Review for First Line Use of TRISENOX® (arsenic trioxide) in Patients with Low to Intermediate Ri...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201710h00PR Newswire (US)Teva Presents First Real-World Evidence Demonstrating Treatment with DuoResp Spiromax® Inhaler was Comparable to Symbicort T...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201709h03Dow Jones NewsOpioid Makers Challenge Suit -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201709h02Dow Jones NewsTeva Fills CEO Spot After Long Search -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201701h14Dow Jones NewsOpioid Painkiller Makers Seek to Dismiss State LawsuitNYSE:TEVATeva Pharmaceutical Industries Ltd
12/09/201700h08Dow Jones NewsADRs End Higher; Teva Trades ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201723h33Dow Jones NewsTeva Pharmaceutical to Sell Paragard Rights to Medical-Device Firm Cooper For $1.1 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201722h15GlobeNewswire Inc.The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD® IUD From TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201722h15Business WireTeva Announces Sale of PARAGARD® (intrauterine copper contraceptive) to CooperSurgicalNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201720h25Dow Jones NewsTeva Finally Appoints New Chief Executive After Months of Speculation -- 4th UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201714h42Dow Jones NewsTeva Finally Appoints New Chief Executive After Months of Speculation -- 3rd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
11/09/201712h46Dow Jones NewsTeva Names Kare Schultz as New Chief Executive -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
NKE
Nike
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
EU
CAP
Capgemini
NYSE
MCD
McDonalds
EU
EN
Bouygues
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés